• Skip to main content
  • Skip to footer

University of Tennessee Research Foundation

Technology Transfer & Licensing

  • About
    • Our Mission
    • Foundation Details
    • Student Opportunities
    • Staff
    • Subsidiaries
  • Technologies
    • Available Technologies
    • Express Licensing
  • For Innovators
    • Accelerate Fund
    • Resources
    • IDEA Tutorial & Manuals
    • Technology Transfer Process
    • Business Incubator
    • Technology Maturation Grant Funding
  • Media
    • News
    • Newsletters
    • Annual Reports
  • Contact
  • UT Ventures

License Agreement

UTRF Administrator / February 25, 2022

IP isn’t just about patents: UTIA Extension startup licenses technology that streamlines large-plot trials

On-farm, large-plot variety strip trials are an important way to evaluate crop production under realistic conditions, benefiting farmers, seed companies and researchers. Staff and faculty at the University of Tennessee Institute of Agriculture (UTIA)  –- work with regional growers and producers to conduct large-plot trials. While on-farm data is essential, these trials take time, leading (read more)

UTRF Administrator / July 26, 2021

UTRF Develops Agreement Enabling Rapid, Long-term Collaboration with Moderna to Fight COVID-19

During the height of the COVID-19 pandemic, the University of Tennessee Research Foundation was hard at work facilitating relationships to connect groundbreaking research from University of Tennessee campuses and institutes with industry need. At the University of Tennessee Health Science Center in Memphis, UTRF entered into a hybrid agreement with Moderna to leverage technology, expertise (read more)

UTRF Administrator / April 27, 2021

UTRF Startup Uses Audio Analytics to Predict Future Gastrointestinal Impairment

Gastrointestinal impairment (GII) is acute paralysis of the GI tract beginning two to seven days after major abdominal surgery. Around 25 percent of patients develop GII due to postoperative ileus (POI), a small bowel blockage or another postoperative complication. GII puts patients at risk and leads to readmission rates exceeding 20 percent following surgery. One (read more)

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 9
  • Go to Next Page »

Footer

  • LinkedIn
  • Twitter
  • YouTube

Knoxville Office

400 W. Summit Hill Drive
UT Tower 961A
Knoxville, TN 37902
Phone: 865-974-1882

Memphis Office

UT Health Science Center
910 Madison Avenue, Suite 827
Memphis, TN 38163
Phone: 901-448-7827

Copyright © 2026


University of Tennessee Campuses & Institutes

  • UT Knoxville
  • UT Chattanooga
  • UT Southern
  • UT Martin
  • UT Health Science Center
  • UT Institute of Agriculture
  • UT Institute for Public Service
  • UT Alumni Association
  • UT Foundation
  • UT Research Park
X